rs10500321

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001394894.2(NLRP11):​c.1842-191T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 152,246 control chromosomes in the GnomAD database, including 2,091 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2091 hom., cov: 33)

Consequence

NLRP11
NM_001394894.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.765

Publications

3 publications found
Variant links:
Genes affected
NLRP11 (HGNC:22945): (NLR family pyrin domain containing 11) This gene is a member of the the NOD-like receptor protein (NLRP) gene family and encodes a protein with an N-terminal pyrin death (PYD) domain and nucleoside triphosphate hydrolase (NACHT) domain and a C-terminal leucine-rich repeats (LRR) region. This gene has been shown to regulate caspases in the proinflammatory signal transduction pathway and, based on studies of other members of the NLRP gene family with similar domain structure, is predicted to form part of the multiprotein inflammasome complex. Alternative splicing produces multiple transcript variants encoding distince isoforms. [provided by RefSeq, May 2017]
NLRP11 Gene-Disease associations (from GenCC):
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001394894.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.256 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001394894.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP11
NM_001394894.2
MANE Select
c.1842-191T>C
intron
N/ANP_001381823.1P59045-1
NLRP11
NM_145007.5
c.1842-191T>C
intron
N/ANP_659444.2P59045-1
NLRP11
NM_001385451.2
c.1841+564T>C
intron
N/ANP_001372380.1P59045-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP11
ENST00000589093.6
TSL:1 MANE Select
c.1842-191T>C
intron
N/AENSP00000466285.1P59045-1
NLRP11
ENST00000592953.5
TSL:1
c.1545-191T>C
intron
N/AENSP00000468196.1P59045-3
NLRP11
ENST00000590409.5
TSL:1
n.1545-191T>C
intron
N/AENSP00000466582.1K7EMN8

Frequencies

GnomAD3 genomes
AF:
0.149
AC:
22649
AN:
152128
Hom.:
2086
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.260
Gnomad AMI
AF:
0.0658
Gnomad AMR
AF:
0.156
Gnomad ASJ
AF:
0.157
Gnomad EAS
AF:
0.179
Gnomad SAS
AF:
0.0507
Gnomad FIN
AF:
0.0402
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.103
Gnomad OTH
AF:
0.138
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.149
AC:
22668
AN:
152246
Hom.:
2091
Cov.:
33
AF XY:
0.144
AC XY:
10684
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.260
AC:
10780
AN:
41504
American (AMR)
AF:
0.156
AC:
2390
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
544
AN:
3470
East Asian (EAS)
AF:
0.178
AC:
925
AN:
5184
South Asian (SAS)
AF:
0.0503
AC:
243
AN:
4830
European-Finnish (FIN)
AF:
0.0402
AC:
427
AN:
10628
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.103
AC:
6981
AN:
68012
Other (OTH)
AF:
0.135
AC:
286
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
955
1910
2864
3819
4774
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0771
Hom.:
151
Bravo
AF:
0.163
Asia WGS
AF:
0.101
AC:
353
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
1.3
DANN
Benign
0.32
PhyloP100
-0.77
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10500321;
hg19: chr19-56319571;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.